- Posts by Christine Burke WorthenMember of the Firm
Health care providers, payers, digital health companies, and investors call on attorney Christine Burke Worthen for legal and strategic advice as they navigate complex regulatory and business challenges in the continuously ...
On July 10, 2025, the Centers for Medicare & Medicaid Services (CMS) announced a proposed rule to establish the Ambulatory Specialty Model (ASM)—a mandatory value-based payment model for specialists who treat patients with heart failure or low back pain.
CMS selected heart failure and low back pain because these chronic conditions represent roughly 6% of total, annual spend for traditional Medicare. The model is scheduled to run from 2027 through 2031 and represents an expansion of CMS’s strategy to integrate specialty care into its broader efforts to manage chronic disease and control Medicare spending.
CMS is accepting public comments on the proposal through September 12, 2025, offering stakeholders an opportunity to help shape the model’s design and implementation.
As we noted in our previous blog post, HealthBench, an open-source benchmark developed by OpenAI, measures model performance across realistic health care conversations, providing a comprehensive assessment of both capabilities and safety guardrails that better align with the way physicians actually practice medicine. In this post, we discuss the legal and regulatory questions HealthBench addresses, the tool’s practical applications within the health care industry, and its significance in shaping the future of artificial intelligence (AI) in medicine.
The Evolution of Health Care AI Benchmarking
Artificial Intelligence (AI) foundation models have demonstrated impressive performance on medical knowledge tests in recent years, with developers proudly announcing their systems had “passed” or even “outperformed” physicians on standardized medical licensing exams. Headlines touted AI systems achieving scores of 90% or higher on the United States Medical Licensing Examination (USMLE) and similar assessments. However, these multiple-choice evaluations presented a fundamentally misleading picture of AI readiness for health care applications. As we previously noted in our analysis of AI/ML growth in medicine, a significant gap remains between theoretical capabilities demonstrated in controlled environments and practical deployment in clinical settings.
These early benchmarks—predominantly structured as multiple-choice exams or narrow clinical questions—failed to capture how physicians actually practice medicine. Real-world medical practice involves nuanced conversations, contextual decision-making, appropriate hedging in the face of uncertainty, and patient-specific considerations that extend far beyond selecting the correct answer from a predefined list. The gap between benchmark performance and clinical reality remains largely unexamined.
“ERISA, you’ll need a lawyer for that.” Our practice group’s tagline is meant to be a shorthand for the alphabet soup of laws that apply to employee benefits, including the Employee Retirement Income Security Act (ERISA). Employee benefits compliance has many traps for the unwary and is ever evolving. Below, we have provided a primer on current issues of importance in the employee benefits area to help in-house attorneys identify potential risks, mitigate them, and know when to call an outside ERISA lawyer.
1. What Is Old Is New: Get Your Health Plan Governance in Order
Employers that sponsor self-funded health plans have a host of complicated obligations. There are greater potential legal, regulatory, and fiduciary risks than in years past with managing health plans because of increased congressional legislation, increased Department of Labor (DOL) focus on group health plan compliance, and increased group health plan litigation, often by the same plaintiffs’ firms that have been suing 401(k) plans in fee litigation the past 20 years or more.
Blog Editors
Recent Updates
- DOJ False Claims Act Priorities: Cybersecurity Is Still on the Radar
- DOJ Launches Cross-Agency Trade Fraud Task Force: What Importers and Businesses Need to Know
- The AI Doctor Is Out? How California’s AB 489 Could Limit AI Development in Healthcare
- Complex Billing and Reasonable Interpretations: Jury Was Entitled to Find Fraud in Doctor’s Upcoding of Speedy COVID-19 Tests, Fourth Circuit Says
- Governor Kotek Signs Oregon’s SB 537, Strengthening Workplace Violence Prevention in Health Care